NCT04492020 Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult Participants Status COMPLETED Phase PHASE3
NCT04480086 Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis Status TERMINATED Phase PHASE1
NCT04477486 Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT04472598 Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis Status COMPLETED Phase PHASE3
NCT04468984 Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04464187 A Study to Evaluate Pregnancy Outcomes in Females Treated With Oral Elagolix Tablets and Capsules Status TERMINATED Phase N/A
NCT04454658 Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04451772 A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State Status COMPLETED Phase PHASE2
NCT04451720 Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis Status COMPLETED Phase PHASE3
NCT04445025 Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis Status COMPLETED Phase EARLY_PHASE1
NCT04437433 A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine Status COMPLETED Phase PHASE3
NCT04435600 A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms Status COMPLETED Phase PHASE3
NCT04433442 Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis Status COMPLETED Phase N/A
NCT04430855 A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms Status COMPLETED Phase PHASE2
NCT04424641 A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT04417465 First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors Status COMPLETED Phase PHASE1
NCT04416451 A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04403763 Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia Status TERMINATED Phase PHASE1/PHASE2
NCT04401748 Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE3